Cannabis edibles: Labels should convey THC levels more accurately February 11, 2020 AggregatedNews Medical Marijuana, Packaging 0 Comments Most young adults do not understand the advertised levels of tetrahydrocannabinol (THC) in edibles, a new study finds, but the researchers have come up with better way of communicating this information on labels. Research from 2015–2016 shows that, in the… Read More→
N.J. company must pay for employee’s medical marijuana, appeals court rules January 16, 2020 AggregatedNews Medical Marijuana, New Jersey, Policy & Legal 0 Comments In a ruling that could have far-reaching effects, an appeals court in New Jersey ruled this week that a contractor must reimburse a former employee for the cost of the medical marijuana that he uses to treat his incessant pain… Read More→
Medicine Man Technologies Acquisiton Target, MedPharm, to Launch a Landmark Randomized Clinical Trial Taking Aim at Treating Alzheimer’s with Cannabis December 5, 2019 Press Release Medical Marijuana, Press Releases, Science and Technology 0 Comments PRESS RELEASE DENVER--(BUSINESS WIRE)--Medicine Man Technologies Acquisiton Target, MedPharm, to Launch a Landmark Randomized Clinical Trial Taking Aim at Treating Alzheimer’s with Cannabis (Graphic: Business Wire) MedPharm will be exploring the action of a research-based, scientifically formulated compound containing cannabinoids… Read More→
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease December 4, 2019 Press Release Medical Marijuana 0 Comments Patent extends patent coverage for eltoprazine to 2034 New York, NY, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (“Amarantus,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative… Read More→
‘The Big Hurt’ baseball legend Frank Thomas turns to CBD October 22, 2019 AggregatedNews Industry People, Medical Marijuana 0 Comments Ex-baseball star Frank Thomas – AKA ‘The Big Hurt’ – has teamed up with the producers of a CBD pain cream. The Major League Baseball Legend and Hall of Famer says he is no stranger to pain having endured six… Read More→
A bigger crop: Why Maryland’s medical pot growers are adding more plants September 11, 2019 AggregatedNews Maryland, Medical Marijuana 0 Comments WARWICK, Md. — The air inside SunMed Growers’ sprawling, $10 million marijuana greenhouse was thick with the citrusy aroma of freshly harvested Lemon Skunk. Outside, heavy machinery cleared land for about 30,000 additional plants. “This is tripling for medical,” said owner… Read More→
How Weed Tech Companies Are Letting Smokers Control Their High September 10, 2019 AggregatedNews Medical Marijuana, Science and Technology 0 Comments From the medical community into the recreational market, tech companies are tackling an age-old marijuana problem: How can cannabis users get the consistent high they want? The Gofire vaporizer looks like a walkie-talkie with a mouth groove on top. Hardly… Read More→
Classifying Medical Cannabis vs. Traditional Pharmaceuticals Guides Marketing Efforts September 3, 2019 John Taenzler Marketing, Medical Marijuana, Spotlight 0 Comments When considering Medical Cannabinoid Therapy (MCT), most informed physicians and patients focus on two classes of cannabinoids: tetrahydrocannabinols (THC) and cannabidiols (CBD). However, research has identified over 500 compounds in cannabis, including over 120 distinct cannabinoids and over 100 terpenes. Despite… Read More→
Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer August 20, 2019 AggregatedNews Medical Marijuana, Science and Technology 0 Comments Pancreatic cancer is particularly refractory to modern therapies, with a 5-year survival rate for patients at a dismal 8%. One of the significant barriers to effective treatment is the immunosuppressive pancreatic tumor microenvironment and development of resistance to treatment. New… Read More→
Marijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring August 7, 2019 AggregatedNews Cannabis Investments, Medical Marijuana, On the Move 0 Comments GW Pharmaceuticals PLC reported Tuesday afternoon that sales of its cannabis-derived epilepsy drug more than doubled from the previous quarter, sending shares spiking more than 11% higher in after-hours trading. GW Pharmaceuticals GWPH, +10.22% reported second-quarter sales of $68.4 million for Epidiolex, which uses… Read More→
Scientists unlock the secrets of marijuana’s pain-relief potential, study says July 24, 2019 AggregatedNews Cannabis & Hemp Research, Medical Marijuana 0 Comments Researchers have uncovered how marijuana plants produce pain-killing molecules that are 30 times stronger than aspirin — a property that gives them medicinal promise as a substitute for opioid pain relievers, which can lead to crippling addiction, researchers said. “There’s… Read More→
Legal Implications for Physicians Recommending Medical Cannabis in the USA July 17, 2019 John Taenzler Medical Marijuana 0 Comments In our studies examining the use of Medical Cannabis Therapy (MCT) by Oncologists and Pain Management Specialists[i], we asked physicians what their biggest barrier was to their adoption of medical cannabis. Two-thirds (65%), mention legal concerns. Concern for legal exposure… Read More→
Active athletes use cannabis for pain and well-being July 9, 2019 Joanna Zeiger Medical Marijuana 0 Comments The conventional wisdom is that recreational cannabis users are "stoners" and that medical users are too sick to be functional. What if I told you that a recent survey of adult athletes showed that cannabis use and exercise can be… Read More→
How About a Holiday? June 24, 2019 Dr. Dorothy Colagiovanni Cannabis & Hemp Research, Medical Marijuana, Science and Technology 0 Comments The concept of a drug holiday is standard medical practice for chronic users of pharmaceutical medications. Physicians use this abstinence tactic for a variety of reasons, including: limiting side effects of a medicine or allowing a patient to maintain sensitivity… Read More→
Columbia Care Announces Launch of Pioneering Research Study to Identify Genetic Factors Affecting the Efficacy and Safety of Medical Cannabis June 21, 2019 Press Release Medical Marijuana, Press Releases 0 Comments PRESS RELEASE First-of-their-kind results to enhance patient experience and efficacy of Columbia Care products by further informing and personalizing treatment recommendations to support optimal product dosing and formulation selection NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (“Columbia Care” or the “Company”) (NEO:… Read More→